Clinical Trials Logo

Dental Anxiety clinical trials

View clinical trials related to Dental Anxiety.

Filter by:

NCT ID: NCT01798355 Completed - Dental Anxiety Clinical Trials

Children and Adolescents With Dental Anxiety - Randomized Controlled Study of Cognitive Behavioral Therapy

Start date: January 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether cognitive behaviour therapy is effective in the treatment of children and adolescents with dental anxiety. Our hypothesis is that children and adolescents who have been offered CBT shows significant better performance on outcome measures compared with patients in control group who have received treatment as usual.

NCT ID: NCT01622374 Completed - Dental Anxiety Clinical Trials

Effects of "Music for the Mind" on Pre-operative Anxiety in Dentistry

Start date: January 2011
Phase: Phase 2/Phase 3
Study type: Interventional

To examine the pre-operative effect of music for the mind compared to some other styles of music in patients undergoing dental procedures.

NCT ID: NCT01612130 Completed - Blood Pressure Clinical Trials

Valerian for Conscious Sedation in Patients Submitted to Impacted Lower Third Molars Surgery

Start date: March 2003
Phase: N/A
Study type: Interventional

The aim of the present study was to evaluate the efficacy of Valeriana officinalis L. 100 mg in single oral doses one hour preoperative as conscious sedation during the impacted lower third molar surgery.

NCT ID: NCT00695630 Completed - Dental Anxiety Clinical Trials

Flumazenil Reversal of Oral Triazolam

Start date: September 2006
Phase: Phase 1/Phase 2
Study type: Interventional

An increase in the utilization of anesthesia and sedation medications by non-anesthesiologists, including dentists, has grown dramatically. This has been prompted, in part, by the need for pharmacological tools to address high levels of fear and anxiety about dental care among the US population and the evidence of oral health disparities among those who are fearful . Given the prevalence of dental fear in the general population and in the various populations with the greatest burden of oral diseases, effective sedation techniques are needed that are safe and effective in the hands of general dentists that make up the "front line" in the efforts to reduce oral health disparities. This study is to determine whether, when compared to a saline placebo, a single intraoral submucosal administration of the benzodiazepine antagonist flumazenil (0.2 mg) is capable of attenuating in 10 minutes or less the central nervous system (CNS) depression produced by a paradigm of stacked sublingual dosing of triazolam (3 doses of 0.25 mg over 90 minutes).

NCT ID: NCT00609648 Completed - Dental Anxiety Clinical Trials

Computer Assisted Relaxation Learning for Dental Offices

CARL
Start date: January 2008
Phase: N/A
Study type: Interventional

This is a randomized study in which two groups will be used to compare the effectiveness of a computerized psychological therapy compared to an information only control group (pamphlet) for reducing fear of dental injections.

NCT ID: NCT00355693 Not yet recruiting - Surgery Clinical Trials

Effect Site Controlled, Reaction Time Safeguarded, Patient Maintained Sedation With Propofol in Anxious Patients

Start date: October 2006
Phase: Phase 4
Study type: Interventional

Whether patient-maintained sedation (the patient controls his/her degree of sedation using a hand-held device) using the drug propofol is safer and more effective when using deteriorating reaction time as an added safeguard against the potential for over sedation in a groups of patients undergoing oral surgery, general dentistry and colonoscopy.

NCT ID: NCT00245609 Completed - Dental Anxiety Clinical Trials

Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure

Start date: January 2006
Phase: Phase 2
Study type: Interventional

The primary purpose of the trial is to assess how effective pregabalin, alprazolam, and placebo are at reducing anxiety levels of subjects who take a dose of these treatments 4 hours before a scheduled dental procedure.